Управляемое лечение больных сахарным диабетом типа 2: результаты исследования ADVANCE
Управляемое лечение больных сахарным диабетом типа 2: результаты исследования ADVANCE
Карпов Ю.А. Управляемое лечение больных сахарным диабетом типа 2: результаты исследования ADVANCE. Consilium Medicum. 2008; 10 (11): 36–40.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Список литературы
1. Adler A, Stratton IM, Neil H et al. Assoсiation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–9.
2. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–87.
3. The Task Forсе on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88–136.
4. Stratton IM, Adler AL, Neil HA et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–13.
6. The АDVANCE Collaborative Group: Rationale and design of the АDVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21–28.
7. АDVANCE Collaborative Group/ADVANCE – Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet. Med. 2005; 1–7.
8. ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828–40.
9. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
10. National Heart, Lung and Blood Institute ACCORD News Conference: 6 Feb. 2008.
11. Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163–5.
12. Goede P, Lund-Andersen H, Parving HH et al. Effect of multifactorial intervention on mortality in tipe 2 diabetes. N Engl J Med 2008; 358: 580–9.
13. Holman RR, Paul SJ, Bethel MA et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359 (15); 1577–89.
14. Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.
2. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–87.
3. The Task Forсе on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88–136.
4. Stratton IM, Adler AL, Neil HA et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–13.
6. The АDVANCE Collaborative Group: Rationale and design of the АDVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21–28.
7. АDVANCE Collaborative Group/ADVANCE – Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet. Med. 2005; 1–7.
8. ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828–40.
9. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
10. National Heart, Lung and Blood Institute ACCORD News Conference: 6 Feb. 2008.
11. Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163–5.
12. Goede P, Lund-Andersen H, Parving HH et al. Effect of multifactorial intervention on mortality in tipe 2 diabetes. N Engl J Med 2008; 358: 580–9.
13. Holman RR, Paul SJ, Bethel MA et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359 (15); 1577–89.
14. Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.
Авторы
Ю.А. Карпов
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.